Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0000905148-24-001060

Director acquired 150,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Fust Matthew K Director 2024-03-31 Grant or award +150,000 259,000 D
Loading xslF345X05/form4.xml…